Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • us food and drug...

    Tag: us food and drug administration

    You Searched For "us food and drug administration"
    Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma

    Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma

    Medical Dialogues Bureau14 May 2019 4:17 AM GMT
    The USFDA has removed the boxed warning from the CYRAMZA labelling which highlighted warnings pertaining to haemorrhage, gastrointestinal perforation a...
    Pfizer acquires clinical-stage Biotech Therachon for $810 million

    Pfizer acquires clinical-stage Biotech Therachon for $810 million

    Garima12 May 2019 4:15 AM GMT
    NEW YORK: Pfizer recently announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately...
    Eli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptions

    Eli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptions

    Farhat Nasim12 May 2019 4:00 AM GMT
    Weekly U.S. prescription data from IQVIA, an analytics provider to the life sciences industry, showed that Lilly's therapy Emgality claimed the largest...
    Following opioid suits, family behind deadly OxyContin squabbles

    Following opioid suits, family behind deadly OxyContin squabbles

    Medical Dialogues Bureau11 May 2019 3:30 AM GMT
    NEW YORK: A united front among members of the billionaire Sackler family behind painkiller OxyContin is showing signs of strain from litigation over...
    Unichem Labs gets tentative USFDA nod for generic version of JnJ Zyrtec-D 12 Hour

    Unichem Labs gets tentative USFDA nod for generic version of JnJ Zyrtec-D 12 Hour

    Farhat Nasim9 May 2019 4:45 AM GMT
    Unichem Lab's approved drug is a generic copy of Zyrtec-D 12 Hour which is used for treating allergic rhinitis.New Delhi: Unichem Laboratories Tuesday ...
    Pfizer gets USFDA nod for potential blockbuster heart drug Tafamidis

    Pfizer gets USFDA nod for potential blockbuster heart drug Tafamidis

    Medical Dialogues Bureau7 May 2019 4:15 AM GMT
    Pfizer, which has touted tafamidis as a potential blockbuster product, set a list price of $225,000 a year for the medicine, which would be sold under ...
    AbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patients

    AbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patients

    Farhat Nasim3 May 2019 3:40 AM GMT
    New Delhi: AbbVie Inc. recently won the U.S. Food and Drug Administration (USFDA) approval for Mavyret (glecaprevir and pibrentasvir) tablets to treat ...
    USFDA declines to approve Nabriva

    USFDA declines to approve Nabriva's antibiotic Contepo for urinary tract infections

    Medical Dialogues Bureau1 May 2019 6:32 AM GMT
    The U.S. Food and Drug Administration on Tuesday declined to approve Nabriva Therapeutics Plc's antibiotic Contepo for complicated urinary tract...
    Using AI to detect mental health disorders likely to be counterproductive

    Using AI to detect mental health disorders likely to be counterproductive

    Medical Dialogues Bureau30 April 2019 3:30 AM GMT
    AI-based vocal analytics may allow patients to detect the disease at home by just speaking into a smartphone application, eliminating the need to be ph...
    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Farhat Nasim29 April 2019 4:05 AM GMT
    The positive CHMP opinion of TALZENNA follows the medicine's approval by the U.S. Food and Drug Administration (FDA) in October 2018.New Delhi:...
    USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose

    USFDA nod to Teva generic nasal spray-Narcan to treat opioid overdose

    Medical Dialogues Bureau21 April 2019 3:57 AM GMT
    The U.S. Food and Drug Administration granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a...
    Sun Pharma launches cancer drug INFUGEM in US market

    Sun Pharma launches cancer drug INFUGEM in US market

    Farhat Nasim9 April 2019 4:35 AM GMT
    Sun Pharma said INFUGEM uses its proprietary technology which allows cytotoxic oncology products to be premixed in a sterile environment and supplied t...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 27 May 2022 6:45 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X